✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Insulet Corp

Common Name
Insulet
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
5,400
Ticker
PODD
Exchange
NASDAQ/NGS
Description
Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-depe...

Insulet's GHG Emissions Data Preview

In 2025, Insulet completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Insulet has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022-2019
Total Scope 1
1,747a
1,383a
1,316a
Total Scope 2
Market-Based
10,800a
11,467a
3,977a
Location-Based
10,637a
11,057a
3,574a
Total Scope 3
N/AN/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
0.6451a
0.6676a
0.7754a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=PODD&reporting_period=2025"

Verified Sources Behind Insulet’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Insulet's Sustainability Report 2025
b. Insulet's ESG Data Spreadsheet 2021

Insights into Insulet's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Insulet amounted to 12,384 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Insulet decreased by 0.45%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Insulet's Scope 1 Emissions Over Time

20202021202220232024202504509001.35 k1.8 ktCO2e-17%+3%-10%+5%+26%
  • Total Scope 1
  • Year-over-Year Change

What are Insulet's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Insulet were 1,747 metric tons of CO₂ equivalent (tCO₂e).a

Has Insulet reduced its Scope 1 emissions over time?

Since 2020, Insulet's Scope 1 emissions have increased by 2.22%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2024), Insulet's Scope 1 emissions increased by 26.32%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Insulet's Scope 2 emissions?

In 2025, Insulet reported Scope 2 greenhouse gas (GHG) emissions of 10,800 tCO₂e using the market-based method and 10,637 tCO₂e using the location-based method.a

Has Insulet reduced its Scope 2 emissions over time?

Since 2020, Insulet's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 367.97%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2024), Insulet's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Insulet's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Insulet use for Scope 2 reporting?

In 2025, Insulet reported its Scope 2 emissions using the market-based method and using the location-based method.a

Insulet's Scope 2 Emissions Over Time

20202021202220232024202503 k6 k9 k12 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Insulet’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Insulet reported Scope 1 greenhouse gas (GHG) emissions of 1,747 tCO₂e and total revenues of USD 2,708 millions. This translates into an emissions intensity of 0.65 tCO₂e per millions USD.a

Insulet's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1001,0005,00020,000100,000Revenues (Millions of USD)SysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MGetinge publYear: 2025Scope 1: 11,650 tCO2eRevenue: $M 3,802Scope 1 Intensity: 3.06 tCO2e/$MDemantYear: 2025Scope 1: 15,893 tCO2eRevenue: $M 3,616Scope 1 Intensity: 4.40 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$MVarex ImagingYear: 2023Scope 1: 4,856 tCO2eRevenue: $M 893Scope 1 Intensity: 5.44 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MConmedYear: 2025Scope 1: 6,252 tCO2eRevenue: $M 1,375Scope 1 Intensity: 4.55 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MHaemoneticsYear: 2025Scope 1: 3,101 tCO2eRevenue: $M 1,361Scope 1 Intensity: 2.28 tCO2e/$MZimmer Biomet HoldingsYear: 2025Scope 1: 15,094 tCO2eRevenue: $M 8,231Scope 1 Intensity: 1.83 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MGE Healthcare TechnologiesYear: 2025Scope 1: 104,000 tCO2eRevenue: $M 20,625Scope 1 Intensity: 5.04 tCO2e/$MEdwards LifesciencesYear: 2025Scope 1: 9,391 tCO2eRevenue: $M 6,068Scope 1 Intensity: 1.55 tCO2e/$MBoston ScientificYear: 2025Scope 1: 91,488 tCO2eRevenue: $M 20,074Scope 1 Intensity: 4.56 tCO2e/$MStrykerYear: 2024Scope 1: 66,449 tCO2eRevenue: $M 22,595Scope 1 Intensity: 2.94 tCO2e/$MAbbott LaboratoriesYear: 2025Scope 1: 499,000 tCO2eRevenue: $M 44,328Scope 1 Intensity: 11.26 tCO2e/$MGlaukosYear: 2025Scope 1: 533 tCO2eRevenue: $M 507Scope 1 Intensity: 1.05 tCO2e/$MIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MInteger HoldingsYear: 2024Scope 1: 54,000 tCO2eRevenue: $M 1,717Scope 1 Intensity: 31.46 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MBio Rad LaboratoriesYear: 2025Scope 1: 21,397 tCO2eRevenue: $M 2,583Scope 1 Intensity: 8.28 tCO2e/$MInsuletYear: 2025Scope 1: 1,747 tCO2eRevenue: $M 2,708Scope 1 Intensity: 0.65 tCO2e/$M

How does Insulet's GHG emissions intensity compare to its peers?

In 2025, Insulet reported a Scope 1 emissions intensity of 0.65 tCO₂e per millions USD. Compared to the peer group median of 3.06, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Insulet rank on GHG emissions intensity within its industry?

In 2025, Insulet ranked 2 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Insulet among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Insulet's GHG Emissions Dataset?
Start 30-Day Free Trial